<DOC>
	<DOC>NCT01710098</DOC>
	<brief_summary>How are testosterone levels of patients with prostate cancer under treatment with Firmagon速 changing. Former studies showed a quick fall of testosterone levels after start of therapy with Firmagon速 and a quick recovery when therapy is stopped. The investigators want to prove this in a normal outpatient urologist setting. Furthermore data is collected to prove the adherence to the German S3-Guideline for the treatment of prostate cancer.</brief_summary>
	<brief_title>Treatment of Prostate Cancer With Firmagon速</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>advanced hormonedependent prostate cancer with no other previous hormone therapy for whom irrespectively of this NIS the use of Firmagon速 is intended contraindication for Degarelix</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>testosterone</keyword>
	<keyword>S3-Adherence</keyword>
	<keyword>Quality of Life</keyword>
</DOC>